Canada’s Drug Agency is pleased to announce the recipients of our 2024 Recognition Awards. These awards honour individuals who are pushing the science of health technology assessment (HTA) forward, mentoring the next generation of leaders, and helping to grow Canada’s reputation for excellence in the field.
This year marks the introduction of a new award that recognizes early-career professionals with the potential to become leaders in health economics. The award is named in honour of the late Dr. Murray Krahn, a beloved physician and giant in the field of economic evaluation and HTA.
Dr. Mina Tadrous is at the forefront of research that has led to meaningful change at both the policy and patient level. At the Ontario Drug Policy Research Network (ODPRN), he played a key role in implementing a novel framework for drug class reviews that enhanced standard HTA methods with patient and citizen perspectives and real-world evidence (RWE). This approach is driving formulary modernization in Ontario and elsewhere.
More News
Image
Faces of PharmSci: Cheyenne Matinnia
Clinical Pharmacist and MSc student Cheyenne Matinnia's research focuses on the role of conflict in pharmacy education. While conflict training is well-established in other healthcare fields, it remains largely unexplored for pharmacy students.
Read More
Image
New student award established to recognize leadership in medication safety
Andrew’s Living Legacy Award will support pharmacy students who demonstrate exceptional commitment to medication safety.
Read More
Image
Faces of PharmSci: Stephanie Skalitzky
MSc student Stephanie Skalitzky in the Piquette-Miller lab is exploring whether nutrient supplements can safely prevent inflammation-related issues with placental drug transporters, benefiting maternal and child health.
Read More